HERZLIYA, Israel and CALGARY, AB , Sept. 18, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in...
HERZLIYA, Israel and CALGARY, Alberta , Sept. 15, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer...
HERZLIYA, Israel and CALGARY, Alberta , Aug. 29, 2025 /PRNewswire/ --Â Innocan Pharma Corporation (" Innocan " or the " Company ") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...
HERZLIYA, Israel and CALGARY, AB , Aug. 27, 2025 /PRNewswire/ --Â Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the " Company " or " Innocan "), a...
HERZLIYA, Israel and CALGARY, AB , Aug. 22, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer...
HERZLIYA, Israel and CALGARY, Alberta , July 23, 2025 /PRNewswire/ -- Innocan Pharma Corporation (" Innocan " or the " Company ") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...